Header Logo

Connection

CHRIS AMOS to Cyclin-Dependent Kinase Inhibitor p16

Back to Details
This is a "connection" page, showing publications CHRIS AMOS has written about Cyclin-Dependent Kinase Inhibitor p16.
CHRIS AMOS
Connection Strength
0.082
Cyclin-Dependent Kinase Inhibitor p16
  1. Aurora-A and p16 polymorphisms contribute to an earlier age at diagnosis of pancreatic cancer in Caucasians. Clin Cancer Res. 2007 May 15; 13(10):3100-4.
    View in: PubMed
    Score: 0.064
  2. Polymorphisms of p16, p27, p73, and MDM2 modulate response and survival of pancreatic cancer patients treated with preoperative chemoradiation. Ann Surg Oncol. 2009 Feb; 16(2):431-9.
    View in: PubMed
    Score: 0.018
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.